Oncodesign: no impact











Photo credit © Reuters


(Boursier.com) — Oncodesign remains stable at 14.40 euros on Friday, while the group’s half-year turnover stood at 16.8 ME, mainly driven by the strong organic growth of the Service with external turnover at 16.2 ME (+ 28%) and an order book of 17.8 ME (+14%).
Management stresses the stability of revenues and operating income at 19.3 ME (+5%). Operating income was down at -1.8 ME, due to the general increase in consumables linked to the global economic context passed on by subcontractors and suppliers (+2 ME in costs or +23% in purchases consumed). Cash is 23 ME at June 30, 2022. Portzamparc speaks of a publication “below its expectations but without impact on the share price following the Eylan takeover bid”.


©2022 Boursier.com






Source link -87